Dow Jones

39 411,21

0,67%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Maxpro Capital Acquisition Corporation (JMACU)
Maxpro Capital Acquisition Corporation (JMACU) Actualités

JMACU

Maxpro Capital Acquisition (JMACU)

Maxpro Capital Acquisition Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:JMACU

Date	Heure	Source	Titre	Symbole	Société
10/04/2023	15h01	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
31/03/2023	22h01	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
30/03/2023	14h10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
29/03/2023	23h37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
29/03/2023	22h25	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
14/02/2023	22h56	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
13/01/2023	22h13	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business Combination	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
10/01/2023	22h32	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
10/01/2023	22h05	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business Combination	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
15/11/2022	14h00	GlobeNewswire Inc.	Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
14/09/2022	14h30	GlobeNewswire Inc.	Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
14/02/2022	22h15	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
26/11/2021	15h00	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces the Separate Trading of Its Class A Common Stock and Warrants	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
14/10/2021	00h03	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
13/10/2021	19h10	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
08/10/2021	00h41	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Pricing of $90,000,000 Initial Public Offering	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation